Volume 2, Issue 1 And Supplement (Winter 2021)
J Vessel Circ 2021, 2(1 And Supplement): 33-33 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Basir M, Borhani-Haghighi A, Heydari S T, Yousefi S, Kowkabi S, Shariat A, et al . All-cause, Vascular, and Stroke Mortality in a Midterm Follow-up in Standard and High Risk Patients Having Undergone Carotid Angioplasty and Stenting. J Vessel Circ 2021; 2 (1) :33-33
URL: http://jvessels.muq.ac.ir/article-1-121-en.html
URL: http://jvessels.muq.ac.ir/article-1-121-en.html
Marziyeh Basir1 
, Afshin Borhani-Haghighi * 1, Seyed Taghi Heydari , Samaneh Yousefi1 , Safoora Kowkabi1 , Abdolhamid Shariat1 , Alireza Nikseresht1 , Nahid Ashjazadeh1 , Sadegh Izadi1 , Peyman Petramfar1 , Maryam Poursadegh Fard1 , Abbas Rahimi Jaberi1 , Masoumeh Nazari1 , Maryam Sharifian1 , Vahid Reza Ostovan1
, Afshin Borhani-Haghighi * 1, Seyed Taghi Heydari , Samaneh Yousefi1 , Safoora Kowkabi1 , Abdolhamid Shariat1 , Alireza Nikseresht1 , Nahid Ashjazadeh1 , Sadegh Izadi1 , Peyman Petramfar1 , Maryam Poursadegh Fard1 , Abbas Rahimi Jaberi1 , Masoumeh Nazari1 , Maryam Sharifian1 , Vahid Reza Ostovan1
1- Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract: (915 Views)
Background and Aim: This study presents the risks of all-cause, vascular, and stroke mortality in the mid-term follow up of carotid angioplasty and stenting (CAS) for high and standard risk patients for carotid endarterectomy (CEA).
Materials and Methods: Patients with recent ischemic stroke and with >50% stenosis (symptomatic) and with >80% stenosis (asymptomatic) in catheter angiography were included. Follow-up visits were conducted at third month and every 6 months later. All-cause mortality, vascular mortality (ischemic stroke or hemorrhagic stroke, myocardial infarction, peripheral vascular disease), and stroke attributed to indexed carotid artery were investigated.
Results: Two hundred ninety-three (293) CAS procedures were documented in the database. Forty-three (43) patients had missed data. Follow-up of 250 patients were performed (65.6 % male, mean age 74 years).
The patients were followed 1-34 months. Out of 36 deaths, 16 (6.4%) were cardio-cerebral vascular related deaths, 20 (8%) non-cardiovascular deaths, and 9 (3.6%) due to unknown reasons. Among vascular deaths, there were 11 ischemic strokes, 4 hemorrhagic stroke, and one myocardial infarction. The overall survival rate for all-cause mortality was 90.1% at 1 year, and 79.3% at 2 years and 59.7% (49.3 for men and 87.9 for women) at 34 months. The survival rate for vascular mortality was 94.4% at one year and 90% at two years and 80.7 % (73 for men and 97.6 for women) at 34 months. Male sex was an independent predictor of all-cause mortality (P=0.003) and vascular mortality (P=0.046).
Conclusion: CAS may guarantee an acceptable stroke-free survival in high and standard surgical risk patients.
Materials and Methods: Patients with recent ischemic stroke and with >50% stenosis (symptomatic) and with >80% stenosis (asymptomatic) in catheter angiography were included. Follow-up visits were conducted at third month and every 6 months later. All-cause mortality, vascular mortality (ischemic stroke or hemorrhagic stroke, myocardial infarction, peripheral vascular disease), and stroke attributed to indexed carotid artery were investigated.
Results: Two hundred ninety-three (293) CAS procedures were documented in the database. Forty-three (43) patients had missed data. Follow-up of 250 patients were performed (65.6 % male, mean age 74 years).
The patients were followed 1-34 months. Out of 36 deaths, 16 (6.4%) were cardio-cerebral vascular related deaths, 20 (8%) non-cardiovascular deaths, and 9 (3.6%) due to unknown reasons. Among vascular deaths, there were 11 ischemic strokes, 4 hemorrhagic stroke, and one myocardial infarction. The overall survival rate for all-cause mortality was 90.1% at 1 year, and 79.3% at 2 years and 59.7% (49.3 for men and 87.9 for women) at 34 months. The survival rate for vascular mortality was 94.4% at one year and 90% at two years and 80.7 % (73 for men and 97.6 for women) at 34 months. Male sex was an independent predictor of all-cause mortality (P=0.003) and vascular mortality (P=0.046).
Conclusion: CAS may guarantee an acceptable stroke-free survival in high and standard surgical risk patients.
Type of Study: Research |
Subject:
stroke
Received: 2021/08/24 | Accepted: 2021/02/28 | Published: 2021/02/28
Received: 2021/08/24 | Accepted: 2021/02/28 | Published: 2021/02/28
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2717-0357
Email: jvessels[at]muq.ac.ir
j.vessels.circul[at]gmail.com
